AKERO THERAPEUTICS INC (AKRO)
Institutional ownership reported to the SEC as of Q4 2025, across 27 quarters.
2
Reporting holders
$1.5K
Reported value
0.0%
Held as options
-248
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $984 | 18 | 0.00% | 5q | +100.0% |
| DekaBank Deutsche Girozentrale | $532 | 20,000 | 0.00% | 14q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 2 | $1.5K | 20,018 | 0 | 1 | 0 | 0.0% |
| Q3 2025 | 250 | $4.2B | 87,970,275 | 38 | 68 | 87 | 1.6% |
| Q2 2025 | 247 | $4.8B | 87,525,820 | 53 | 84 | 83 | 3.0% |
| Q1 2025 | 224 | $3.3B | 79,079,022 | 69 | 83 | 46 | 2.5% |
| Q4 2024 | 181 | $1.9B | 68,207,267 | 28 | 55 | 50 | 1.6% |
| Q3 2024 | 155 | $2.0B | 67,998,928 | 29 | 44 | 54 | 1.3% |
| Q2 2024 | 140 | $1.6B | 66,978,481 | 13 | 54 | 48 | 0.8% |
| Q1 2024 | 157 | $1.8B | 69,044,771 | 33 | 70 | 40 | 1.9% |
| Q4 2023 | 144 | $1.4B | 56,444,410 | 16 | 53 | 41 | 3.9% |
| Q3 2023 | 170 | $2.9B | 52,372,658 | 37 | 68 | 39 | 9.7% |
| Q2 2023 | 142 | $2.5B | 50,990,146 | 21 | 63 | 38 | 4.0% |
| Q1 2023 | 138 | $1.8B | 45,337,612 | 18 | 48 | 47 | 2.1% |
| Q4 2022 | 136 | $2.3B | 40,544,682 | 31 | 57 | 35 | 4.5% |
| Q3 2022 | 151 | $1.8B | 51,004,927 | 59 | 49 | 27 | 3.7% |
| Q2 2022 | 111 | $329.8M | 34,862,929 | 21 | 39 | 24 | 0.1% |
| Q1 2022 | 103 | $499.6M | 35,192,056 | 14 | 33 | 24 | 0.1% |
| Q4 2021 | 98 | $750.1M | 35,409,326 | 7 | 30 | 32 | 0.2% |
| Q3 2021 | 104 | $628.3M | 27,993,147 | 9 | 27 | 33 | 0.4% |
| Q2 2021 | 98 | $705.4M | 27,746,997 | 6 | 42 | 24 | 0.6% |
| Q1 2021 | 110 | $940.4M | 31,507,716 | 26 | 27 | 30 | 2.8% |
| Q4 2020 | 95 | $817.0M | 30,858,426 | 9 | 37 | 23 | 0.3% |
| Q3 2020 | 102 | $894.1M | 28,987,337 | 29 | 40 | 23 | 0.2% |
| Q2 2020 | 79 | $546.2M | 21,858,412 | 19 | 33 | 18 | 0.2% |
| Q1 2020 | 69 | $471.5M | 22,059,386 | 23 | 22 | 18 | 0.8% |
| Q4 2019 | 57 | $423.4M | 19,079,623 | 9 | 24 | 11 | 0.0% |
| Q3 2019 | 54 | $288.3M | 12,743,898 | 24 | 13 | 7 | 0.0% |
| Q2 2019 | 48 | $204.5M | 10,674,595 | 48 | 0 | 0 | 0.0% |